Search

This health economic report presents a cost effectiveness analysis of introducing chickenpox vaccination for children in Sweden from a societal and healthcare perspective. It also includes analyses of costs and cost-savings at national and regional levels.

The Public Health Agency of Sweden has updated the recommendations for mpox vaccination due to increased spread of clade 1.

This report presents the health economic analyses informing the recommendation of herpes zoster vaccination for adults with increased risk for disease.

The Communicable Diseases Ordinance contains 13 criteria that form the basis of an investigation of vaccination programmes. This knowledge base is a scientific review based on these criteria. 

This report presents an analysis of COVID-19 vaccine effectiveness (VE) after a fourth dose in relation to SARS-CoV-2 infection and severe outcomes due to the omicron variant among persons aged 65 years and older in Sweden.

This report describes the monitoring systems for influenza in use during the winter season of 2020–2021 and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons.

This report describes the monitoring and surveillance systems for influenza in use during the 2024–2025 winter season and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons. See also the tables and figures section as well as the

This report describes epidemiological and virological surveillance results for the influenza season of 2022–2023 in Sweden. Data are also compared to previous influenza seasons.

This report is primarily written for health care professionals, particularly those working in maternal and child health care, school health care, primary care, and those working in the counties’ Departments of Communicable Disease Control and Prevention as well as public health officials and

This report describes the monitoring systems for influenza in use during the winter season of 2019–2020 and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons. The report has been prepared for the World Health Organization (WHO)